RBL-2H3 Cells
CAD$545.10*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The RBL-2H3 cell line has become a valuable tool for studying mast cell physiology. RBL-2H3 cells express rat mast cell protease II (RMCP-II) and the c-kit receptor tyrosine kinase, making them a potential model for mast cells. However, conflicting and sometimes misleading data about RBL-2H3 cells have been reported. RBL-2H3 cells have been widely used to investigate various aspects of mast cell function, including degranulation, mast cell stabilizers, and the interaction of FceRI receptors with the cytoskeleton. They express high-affinity IgE receptors and can be activated to secrete histamine and other mediators. Cultivating RBL-2H3 cells is relatively easy, and longer culturing times result in higher cell density. Degranulation is a key feature of RBL-2H3 cells, similar to mast cells and basophils. When allergens crosslink their IgE-bound FceRI receptors, RBL-2H3 cells release preformed and newly synthesized mediators, contributing to immune allergic responses. The degranulation of RBL-2H3 cells has provided insights into basophil degranulation as well. These cells can also undergo degranulation in response to non-immunological stimuli, and there are differences between MMC, RBL-2H3, and CTMC. |
|---|---|
| Organism | Rat |
| Tissue | Peripheral blood |
| Disease | Rat leukemia |
| Synonyms | RBL2H3, RBL 2H3, RBL.2H3 |
Characteristics
| Breed/Subspecies | Wistar |
|---|---|
| Morphology | Fibroblast |
| Growth properties | Adherent |
Regulatory Data
| Citation | RBL-2H3 (Cytion catalog number 305194) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 10116 |
| CellosaurusAccession | CVCL_0591 |
Biomolecular Data
Handling
| Culture Medium | EMEM (MEM Eagle), w: 2 mM L-Glutamine, w: 2.2 g/L NaHCO3, w: EBSS (Cytion article number 820100a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS and 1% NEAA |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305194-120124 | Certificate of Analysis | 23. May. 2025 | 305194 |
| 305194-300625 | Certificate of Analysis | 22. Oct. 2025 | 305194 |
| 305194-041022 | Certificate of Analysis | 23. May. 2025 | 305194 |